Drug profile · INN
nilotinib hydrochloride dihydrate
NILOTINIB HYDROCHLORIDE DIHYDRATE
nilotinib hydrochloride dihydrate (NILOTINIB HYDROCHLORIDE DIHYDRATE) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.
Drug details — nilotinib hydrochloride dihydrate
- US status
- approved
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
nilotinib hydrochloride dihydrate (NILOTINIB HYDROCHLORIDE DIHYDRATE) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is nilotinib hydrochloride dihydrate?
nilotinib hydrochloride dihydrate (NILOTINIB HYDROCHLORIDE DIHYDRATE) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.
What is the brand name for nilotinib hydrochloride dihydrate?
NILOTINIB HYDROCHLORIDE DIHYDRATE is a marketed brand name for nilotinib hydrochloride dihydrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of nilotinib hydrochloride dihydrate?
nilotinib hydrochloride dihydrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.